[HTML] nih.gov

Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease

EM Marinho, JB de Andrade Neto, J Silva… - Microbial …, 2020 - Elsevier
Abstract Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in
humans and that has now been declared a global pandemic by the World Health …
被引用次数：128 相关文章 所有 6 个版本
[PDF] springer.com

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

K Marciniec, A Beberok, P Pęcak, S Boryczka… - Pharmacological …, 2020 - Springer
Background A large body of research has focused on fluoroquinolones. It was shown that
this class of synthetic antibiotics could possess antiviral activity as a broad range of anti …
被引用次数：71 相关文章 所有 12 个版本
[PDF] mdpi.com

In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus

P Eleftheriou, D Amanatidou, A Petrou, A Geronikaki - Molecules, 2020 - mdpi.com
The coronavirus disease, COVID-19, caused by the novel coronavirus SARS-CoV-2, which
first emerged in Wuhan, China and was made known to the World in December 2019 turned …
被引用次数：66 相关文章 所有 15 个版本
[HTML] sciencedirect.com

[HTML][HTML] In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing

Y Kumar, H Singh, CN Patel - Journal of infection and public health, 2020 - Elsevier
Background The rapidly enlarging COVID-19 pandemic caused by the novel SARS-corona
virus-2 is a global public health emergency of an unprecedented level. Unfortunately no …
被引用次数：225 相关文章 所有 11 个版本
[HTML] nih.gov

Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19

LI da Silva Hage-Melim, LB Federico, NKS de Oliveira… - Life Sciences, 2020 - Elsevier
Abstract The new Coronavirus (SARS-CoV-2) is the cause of a serious infection in the
respiratory tract called COVID-19. Structures of the main protease of SARS-CoV-2 (M pro) …
被引用次数：76 相关文章 所有 8 个版本
[HTML] nih.gov

[HTML][HTML] Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis

M Hakmi, EM Bouricha, I Kandoussi, J El Harti… - …, 2020 - ncbi.nlm.nih.gov
The new SARS-CoV-2 coronavirus is the causative agent of the COVID-19 pandemic
outbreak that affected more than 190 countries worldwide with more than 292,000 confirmed …
被引用次数：50 相关文章 所有 9 个版本
[PDF] acs.org

In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease

T Huynh, H Wang, B Luan - The Journal of Physical Chemistry …, 2020 - ACS Publications
Currently, the new coronavirus disease 2019 (COVID-19) is a global pandemic without any
well-calibrated treatment. To inactivate the SARS-CoV-2 virus that causes COVID-19, the …
被引用次数：159 相关文章 所有 7 个版本
[PDF] academia.edu

[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2

RR Narkhede, RS Cheke, JP Ambhore… - Eurasian J. Med …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
被引用次数：143 相关文章 所有 3 个版本
[PDF] researchgate.net

[PDF][PDF] Virtual Screening based prediction of potential drugs for COVID-19

T Sekhar - Combinatorial Chemistry & High Throughput Screening, 2020 - researchgate.net
SARS-CoV-2 is the betacoronavirus responsible for the COVID-19 pandemic. It was listed as
a potential global health threat by WHO due to high mortality, high basic reproduction …
被引用次数：77 相关文章 所有 9 个版本
[HTML] nih.gov

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection

HLB Braz, JA de Moraes Silveira, AD Marinho… - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) is a highly transmissible viral infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical trials …
被引用次数：56 相关文章 所有 7 个版本